TP53 and cancer: GSEA had an advantage in exploring the involved signaling pathways, which revealed that the genes in the high-risk group of TCGA cohorts were significantly enriched in tumor and immune-related pathways such as B cell receptor signaling pathway, T cell receptor signaling pathway, P53 signaling pathway, pathways involved in the pathogenesis of cancer and cell cycle.